Homozygous disruption of Pctp modulates atherosclerosis in apolipoprotein E-deficient mice

Journal of Lipid Research

Volumn 47, Issue 11, 2006, Pages 2400-2407

  Wang, Wen Jun ^a   Baez, Juan M ^b   Maurer, Rie ^a   Dansky, Hayes M ^c,e   Cohen, David E ^a,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Aorta; Cholesterol; Macrophage; Phosphatidylcholine transfer protein; Steroidogenic acute regulatory related transfer domain; Triglycerides

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID DERIVATIVE; PROTEIN PCTP; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GENE MUTATION; HOMOZYGOSITY; HYPERLIPOPROTEINEMIA TYPE 3; MALE; MODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BLOTTING, WESTERN; CHOLESTEROL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HOMOZYGOTE; LIPIDS; LIPOPROTEINS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PHOSPHOLIPID TRANSFER PROTEINS;

EID: 33845569520     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M600277-JLR200     Document Type: Article

References (27)

1. Wirtz, K. W. 1991. Phospholipid transfer proteins. Annu. Rev. Biochem. 60: 73-99.
2. Roderick, S. L., W. W. Chan, D. S. Agate, L. R. Olsen, M. W. Vetting, K. R. Rajashankar, and D. E. Cohen. 2002. Structure of human phosphatidylcholine transfer protein in complex with its ligand. Nat. Struct. Biol. 9: 507-511.
3. Soccio, R. E., and J. L. Breslow. 2003. StAR-related lipid transfer (START) proteins: mediators of intracellular lipid metabolism. J. Biol. Chem. 278: 22183-22186.
4. Cohen, D. E., R. M. Green, M. K. Wu, and D. R. Beier. 1999. Cloning, tissue-specific expression, gene structure and chromosomal localization of human phosphatidylcholine transfer protein. Biochim. Biophys. Acta. 1447: 265-270.
5. Wu, M. K., H. Hyogo, S. Yadav, P. M. Novikoff, and D. E. Cohen. 2005. Impaired response of biliary lipid secretion to a lithogenic diet in phosphatidylcholine transfer protein-deficient mice. J. Lipid Res. 46: 422-431.
6. Baez, J. M., I. Tabas, and D. E. Cohen. 2005. Decreased lipid efflux and increased susceptibility to cholesterol-induced apoptosis in macrophages lacking phosphatidylcholine transfer protein. Biochem. J. 388: 57-63.
7. Baez, J. M., S. E. Barbour, and D. E. Cohen. 2002. Phosphatidylcholine transfer protein promotes apolipoprotein A-I-mediated lipid efflux in Chinese hamster ovary cells. J. Biol. Chem. 277: 6198-6206.
8. Wu, M. K., and D. E. Cohen. 2005. Phosphatidylcholine transfer protein regulates size and hepatic uptake of high-density lipoproteins. Am. J. Physiol. 289: G1067-G1074.
9. Wu, M. K., and D. E. Cohen. 2005. Altered hepatic cholesterol metabolism compensates for disruption of phosphatidylcholine transfer protein in mice. Am. J. Physiol. 289: G456-G461.
10. van Helvoort, A., A. de Brouwer, R. Ottenhoff, J. F. Brouwers, J. Wijnholds, J. H. Beijnen, A. Rijneveld, T. van der Poll, M. A. van der Valk, D. Majoor, et al. 1999. Mice without phosphatidylcholine transfer protein have no defects in the secretion of phosphatidylcholine into bile or into lung airspaces. Proc. Natl. Acad. Sci. USA. 96: 11501-11506.
11. Palinski, W., V. A. Ord, A. S. Plump, J. L. Breslow, D. Steinberg, and J. L. Witztum. 1994. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler. Thromb. 14: 605-616.
12. Daugherty, A., and S. C. Whitman. 2003. Quantification of atherosclerosis in mice. Methods Mol. Biol. 209: 293-309.
13. Sukhova, G. K., Y. Zhang, J. H. Pan, Y. Wada, T. Yamamoto, M. Naito, T. Kodama, S. Tsimikas, J. L. Witztum, M. L. Lu, et al. 2003. Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. J. Clin. Invest. 111: 897-906.
14. Sukhova, G. K., U. Schonbeck, E. Rabkin, F. J. Schoen, A. R. Poole, R. C. Billinghurst, and P. Libby. 1999. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation. 99: 2503-2509.
15. Hyogo, H., S. Roy, B. Paigen, and D. E. Cohen. 2002. Leptin promotes biliary cholesterol elimination during weight loss in ob/ob mice by regulating the enterohepatic circulation of bile salts. J. Biol. Chem. 277: 34117-34124.
16. Shoda, J., K. Oda, H. Suzuki, Y. Sugiyama, K. Ito, D. E. Cohen, L. Feng, J. Kamiya, Y. Nimura, H. Miyazaki, et al. 2001. Etiologic significance of defects in cholesterol, phospholipid, and bile acid metabolism in the liver of patients with intrahepatic calculi. Hepatology. 33: 1194-1205.
17. Scapa, E. F., K. Kanno, W. Wang, and D. E. Cohen. 2005. A key regulatory role for phosphatidylcholine transfer protein (PC-TP) in hepatic triglyceride metabolism: implications for the pathogenesis of non-alcoholic fatty liver disease (Abstract). Hepatology. 42: 508A-509A.
18. Scapa, E. F., K. Kanno, W-J. Wang, and D. E. Cohen. 2006. Regulation of fatty acid fluxes and synthesis in the liver by phosphatidylcholine transfer protein (PC-TP) (Abstract). Gastroenterology. 130: A-86.
19. Kanno, K., E. F. Scapa, W-J. Wang, G. Oranasu, J. Plutzky, and D. E. Cohen. 2006. Phosphatidylcholine transfer protein (PC-TP) is regulated by peroxisome proliferator activated receptor α (PPARα) and participates in PPARα-mediated hepatic triglyceride metabolism (Abstract). Gastroenterology. 130: A-65.
20. Tangirala, R. K., E. M. Rubin, and W. Palinski. 1995. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J. Lipid Res. 36: 2320-2328.
21. Meir, K. S., and E. Leitersdorf. 2004. Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress. Arterioscler. Thromb. Vasc. Biol. 24: 1006-1014.
22. Tabas, I. 2005. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Arterioscler. Thromb. Vasc. Biol. 25: 2255-2264.
23. Kockx, M. M., and A. G. Herman. 2000. Apoptosis in atherosclerosis: beneficial or detrimental? Cardiovasc. Res. 45: 736-746.
24. Rodriguez-Agudo, D., S. Ren, P. B. Hylemon, K. Redford, R. Natarajan, A. Del Castillo, G. Gil, and W. M. Pandak. 2005. Human StarD5, a cytosolic StAR-related lipid binding protein. J. Lipid Res. 46: 1615-1623.
25. Rodriguez-Agudo, D., S. Ren, P. B. Hylemon, R. Montanez, K. Redford, R. Natarajan, M. A. Medina, G. Gil, and W. M. Pandak. 2006. Localization of StarD5 cholesterol binding protein. J. Lipid Res. 47: 1168-1175.
26. Soccio, R. E., R. M. Adams, K. N. Maxwell, and J. L. Breslow. 2005. Differential gene regulation of StarD4 and StarD5 cholesterol transfer proteins. Activation of StarD4 by sterol regulatory element-binding protein-2 and StarD5 by endoplasmic reticulum stress. J. Biol. Chem. 280: 19410-19418.
27. Soccio, R. E., R. M. Adams, M. J. Romanowski, E. Sehayek, S. K. Burley, and J. L. Breslow. 2002. The cholesterol-regulated StarD4 gene encodes a StAR-related lipid transfer protein with two closely related homologues, StarD5 and StarD6. Proc. Natl. Acad. Sci. USA. 99: 6943-6948.